Page 80 - MEMORIA ANUAL 2021

MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
Sánchez-Sánchez MJ, Soria B, Cladera A, Artola MT, García-Guiñón A, Giménez-Conca A, Amador ML, Martínez-Sánchez P, Algarra JL, Vidal MJ, Alonso N, Llorente L, García- Boyero R, Ciudad J, Orfao A .
• Validation of the Burkitt lymphoma international prognostic index (BL-IPI) in patients from two chemoimmunotherapy trials (BURKIMAB-08 and BURKIMAB-14) by the PET- HEMA and GELTAMO groups.
26th Congress of the European-Hematology-Association (EHA). EHA2021 VIRTUAL, Jun 9-17. Ribera JM, García O, Buendía B, Jiménez A, Tormo M, Terol MJ, Vicent A, Vall-Llovera F, Bergua J, García-Cadenas I, Martino R, Esteve J, Montesinos P, Torrent A, Acuña-Cruz E, Herrera P, Hernández-Rivas JM, Barba P, Ribera J, Abrisqueta P, González-Campos J, Rodrí- guez-Medina C, Bastos M, Caminos N, Artola MT, Queipo de Llano MP, Cladera A, Llorente L, Alonso N, García-Guiñón A, Gil C, Suárez S, Genescà E, Penalva MJ, Novo A, Cabañas V, Serrano J, Paumard E, López ME, del Potro E, Bernal T, Varela M, Mateos MC, Salama P, García-Belmonte D, Gimeno E, Ortin X, Barrenetxea C, Arranz R, Mercadal S, Sancho JM .
• Ponatinib and Chemotherapy in Adults with De Novo Philadelphia Chromosome-Pos- itive Acute Lymphoblastic Leukemia. Final Results of Ponalfil Clinical Trial.
63rd Annual Meeting of the American-Society-of-Hematology (ASH). Georgia, Dec 11-14, 2021. Ribera JM, García O, Ribera J, Montesinos P, Cano I, Martínez P, Esteve J, Esteban D, García-Fortes M, Alonso N, González-Campos J, Bermúdez A, Torrent A, Genescà E, Mer- cadal S, Martínez-López J, García-Sanz R .
• Genomic Data Improves Prognostic Stratification in Adult T-Cell Acute Lymphoblas- tic Leukemia Patients Enrolled in Measurable Residual Disease-Oriented Trials.
63rd Annual Meeting of the American-Society-of-Hematology (ASH). Georgia, Dec 11-14, 2021.
González-Gil C, Morgades M, Fuster-Tormo F, García-Chica J, Montesinos P, Torrent A, Díaz-Beyá M, Coll R, Ribera J, Zhao R, Hermosín ML, Mercadal S, González-Campos J, Artola MT, Vall-Llovera F, Tormo M, Gil C, Barba P, Novo A, Bernal del Castillo T, Queipo De Llano M, Martínez P, González T, Cladera A, Serrano A, Fernández-Martín R, Ardaiz MC, Vi- dal MJ, Baena A, López-Bigas N, Bigas A, Maciejewski JP, Orfao A, Ribera JM, Genescà E .
• t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Pro- tocols from the PETHEMA Group.
Clin Lymphoma Myeloma Leuk. Sep 2021;21(Suppl. 1):S270-S271. Abstract: ALL-154. Ribera J, Morgades M, Granada I, Torrent A, Zamora L, González T, Ciudad J, Barrena S, Such E, Avetisyán G, Calasanz MJ, Genescà E, González-Gil C, Fuster-Tormo F, Mercadal
80